Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in TOVX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT, LLC | 450K | $88K | +112.3% | 1.262% | 0.00% |
| 2 | VANGUARD FIDUCIARY TRUST CO | 242K | $47K | β | 0.677% | 0.00% |
| 3 | UBS Group AG | 226K | $44K | +17.9% | 0.632% | 0.00% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 192K | $38K | β | 0.539% | 0.00% |
| 5 | JANE STREET GROUP, LLC | 177K | $35K | β | 0.496% | 0.00% |
| 6 | Ikarian Capital, LLC | 112K | $22K | 0.0% | 0.314% | 0.00% |
| 7 | TWO SIGMA SECURITIES, LLC | 105K | $21K | +145.4% | 0.295% | 0.00% |
| 8 | XTX Topco Ltd | 95K | $19K | +139.9% | 0.265% | 0.00% |
| 9 | BOOTHBAY FUND MANAGEMENT, LLC | 28K | $5K | 0.0% | 0.077% | 0.00% |
| 10 | MORGAN STANLEY | 24K | $5K | -88.2% | 0.066% | 0.00% |
| 11 | INTL FCSTONE INC. | 22K | $4K | -40.1% | 0.062% | 0.00% |
| 12 | TWO SIGMA INVESTMENTS, LP | 15K | $3K | -63.5% | 0.043% | 0.00% |
| 13 | SCHWARZ DYGOS WHEELER INVESTMENT ADVISORS LLC | 15K | $3K | 0.0% | 0.042% | 0.00% |
| 14 | BlackRock, Inc. | 8K | $1K | 0.0% | 0.021% | 0.00% |
| 15 | CITIGROUP INC | 1K | $272 | -77.5% | 0.004% | 0.00% |
| 16 | Virtu Financial LLC | 253K | $50 | β | 0.710% | 0.00% |
| 17 | SBI Securities Co., Ltd. | 131 | $26 | +122.0% | 0.000% | 0.00% |
| 18 | IFP Advisors, Inc | 11 | $2 | 0.0% | 0.000% | 0.00% |
| 19 | ADVISOR GROUP HOLDINGS, INC. | 8 | $1 | -98.2% | 0.000% | 0.00% |
| 20 | Newbridge Financial Services Group, Inc. | 5 | $1 | 0.0% | 0.000% | 0.00% |
| 21 | DANSKE BANK A/S | 1 | $0 | 0.0% | 0.000% | 0.00% |
| 22 | ROYAL BANK OF CANADA | 1 | $0 | β | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in TOVX β a direct measure of their conviction.
Filings activity in TOVX during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 22 | +10% | 3.09% | +0.66 pp | $0M | +27% |
| Q4 2025 | 20 | +5.3% | 2.43% | +0.97 pp | $0M | +67% |
| Q3 2025 | 19 | +12% | 1.46% | +0.42 pp | $0M | +40% |
| Q2 2025 | 17 | +70% | 1.04% | 0.89 pp | $0M | 46% |
| Q1 2025 | 10 | +0.0% | 1.93% | +1.38 pp | $0M | +249% |
| Q4 2024 | 10 | 41% | 0.55% | 5.55 pp | $0M | 91% |
| Q3 2024 | 17 | 29% | 6.10% | 6.15 pp | $1M | 50% |
| Q2 2024 | 24 | β | 12.25% | β | $1M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying TOVX stock.
Based on Q1 2026 13F filings, institutional ownership of Theriva Biologics, Inc. stands at 3.1%, held across 22 reporting institutions.
GEODE CAPITAL MANAGEMENT, LLC is the largest reported institutional holder of TOVX, with approximately 450,263 shares worth $0.00B as of Q1 2026.
Yes β 3 widely-followed marquee investors appear among the top 25 institutional holders of TOVX, including JANE STREET GROUP, LLC, TWO SIGMA SECURITIES, LLC, TWO SIGMA INVESTMENTS, LP.
Our composite Smart Money Score for TOVX is 71 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
5 institutions opened new positions in TOVX during Q1 2026, while 3 fully exited. 5 added to existing positions and 9 trimmed.
TOVX institutional ownership rose by 0.66 percentage points quarter-over-quarter, with a net change of +2 holders.
The top 10 institutions account for 96.4% of all reported 13F value in TOVX, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Theriva Biologics, Inc. (TOVX) Institutional Ownership